Daniels, Gilbert H.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 7,629

Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management

Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 1,800

Chronic Autoimmune Thyroiditis

Dayan, C. M., & Daniels, G. H. (1996) · New England Journal of Medicine

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 904

The Thyrotropin Reference Range Should Remain Unchanged

Surks, M. I., Goswami, G., & Daniels, G. H. (2005) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsClinical Laboratory Practices and Quality Control

Cited by 287

GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide

Hegedüs, L., Moses, A. C., Zdravkovic, M., Le Thi, T., & Daniels, G. H. (2011) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Treatment and ManagementThyroid Cancer Diagnosis and Treatment

Cited by 194

Complications of surgery in hypothyroid patients

Ladenson, P. W., Levin, A. A., Ridgway, E. C., & Daniels, G. H. (1984) · The American Journal of Medicine

Thyroid Disorders and TreatmentsCardiac, Anesthesia and Surgical Outcomes

Cited by 177

Amiodarone-Induced Thyrotoxicosis

Daniels, G. H. (2001) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsAtrial Fibrillation Management and Outcomes

Cited by 159

Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis

Daniels, G. H., Vladic, A., Brinar, V., Zavalishin, I., Valente, W., Oyuela, P., Palmer, J., & Margolin, D. H. (2014) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsMultiple Sclerosis Research Studies

Cited by 150

The Use and Limitations of a Chemiluminescent Thyrotropin Assay as a Single Thyroid Function Test in an Out-Patient Endocrine Clinic*

ROSS, D. S., DANIELS, G. H., & GOUVEIA, D. (1990) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 126

No evidence of increase in calcitonin concentrations or development of C-cell malignancy in response to liraglutide for up to 5 years in the LEADER trial

Hegedüs, L., Sherman, S. I., Tuttle, R. M., von Scholten, B. J., Rasmussen, S., Karsbøl, J. D., Daniels, G. H., & for the LEADER Publication Committee on behalf of the LEADER Trial Investigators (2018) · Diabetes Care

Diabetes Treatment and ManagementThyroid Disorders and Treatments

Cited by 67

Use of Adjunctive Potassium Iodide after Radioactive Iodine (131I) Treatment of Graves' Hyperthyroidism*

ROSS, D. S., DANIELS, G. H., DE STEFANO, P., MALOOF, F., & RIDGWAY, E. C. (1983) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 59

THERAPY OF PRIMARY HYPOTHYROIDISM WITH L‐TRIIODOTHYRONINE: DISCORDANT CARDIAC AND PITUITARY RESPONSES

RIDGWAY, E. C., COOPER, D. S., WALKER, H., DANIELS, G. H., CHIN, W. W., MYERS, G., & MALOOF, F. (1980) · Clinical Endocrinology

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 30